• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Infectious Disease

Single dose mass vaccination against COVID-19 is linked with reductions in hospital admissions

byCyrus AyubchaandTeddy Guo
May 12, 2021
in Infectious Disease, Public Health
Reading Time: 2 mins read
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Share on FacebookShare on TwitterShare on LinkedIn

1. The initial doses of the Pfizer and AstraZeneca vaccines were 91% and 88% efficacious in reducing COVID-19 hospitalizations one month after vaccination.

2. Combined vaccine efficacy of the Pfizer and AstraZeneca in preventing hospital admission due to COVID-19 among those aged 80 years and older was approximately 83%.

Evidence Rating Level: 2 (Good)

Study Rundown: At the time of this publication, the COVID-19 pandemic continues to burden healthcare systems worldwide. In many countries, the demand for vaccines surpasses the available supply. To work around the low vaccine availability, some regions have opted for a first-dose mass vaccination program with a delayed second dose rather than the recommended two-dose regimen with vaccines given three weeks apart. However, the long-term efficacy of various COVID-19 vaccines after a single dose is still largely unknown. In this observational study, the effectiveness of a first dose of either the BNT162b2 mRNA (Pfizer-BioNTech) or ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine in preventing hospital admissions was investigated. This study found that the Pfizer and AstraZeneca vaccines were approximately highly effective in reducing COVID-19-related hospitalizations at approximately one month after the first dose. Overall, this study reports the effectiveness of a single dose mass vaccination program in over one million vaccinated individuals. Nevertheless, the observational nature of this study inclines the results to be confounded by ecological and temporal effects.

Click to read the study in The Lancet

Relevant Reading: Mass-Vaccination Sites — An Essential Innovation to Curb the Covid-19 Pandemic 

RELATED REPORTS

CDC reports increasing early-season influenza activity and at least 900 deaths nationwide

Pennsylvania reports 1,260 measles cases across 43 counties in 2026

FDA approvedFor COVID-19: Xocova (ensitrelvir), May 29, 2026→

In-Depth [prospective cohort]: This study utilized a prospective cohort structure to enroll 1,331,993 subjects between Dec 8, 2020, and Feb 22, 2021. Notably, all those having previously tested positive for COVID-19 were excluded. Treatment exposure was defined as receiving a single dose of either the BNT162b2 mRNA (Pfizer-BioNTech) or ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine between Dec 8, 2020, and Feb 22, 2021. The main outcome was hospital admissions due to COVID-19, or any hospital admission within 28 days of a positive COVID PCR test between Dec 8, 2020, to Feb 22, 2021. Cox models and Poisson regressions were utilized with respective covariates (e.g. comorbidity, smoking status, socioeconomic status etc.); further analyses were utilized to assess certain age groups (18-64, 65-79, >80 yo). A downturn in admissions was observed before the vaccination rollout however further modeling attempted to assess the isolated effects. Vaccine effect at 28-34 days after vaccination led to a reduction in COVID-19 hospital admissions (Pfizer 91% [95% CI 85-94], AstraZeneca 88% [95% CI 75-94]). In a pooled analysis of both vaccines, similar findings were observed among patients aged 18-64 years (92%, 95% CI 82-97), 65-79 years (93%, 95% CI 73-98), and those aged 80 years or older (83%, 95% CI 72-89).

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: astrazenecabnt162b2ChAdOx1ChAdOx1 nCoV-19 vaccineChAdOx1 vaccinecovidCOVID-19 antibodiescovid-19 diagnosiscovid-19 infectionCOVID-19 Vaccinemass vaccinationpfizervaccinationvaccine
Previous Post

Routine urinary tract cancer testing among all patients with microhematuria has low diagnostic yield

Next Post

#VisualAbstract: Convalescent plasma transfusion provides mortality benefit in early COVID-19 disease stage

RelatedReports

The image features vials of a vaccine, a patient using a respiratory device, and medical devices highlighting aspects of infectious disease management, likely related to influenza.
2MM Trial Briefs

CDC reports increasing early-season influenza activity and at least 900 deaths nationwide

October 31, 2026
An illustration depicting two syringes near a stylized representation of a human arm, symbolizing the administration of flu and COVID-19 vaccinations.
2MM Trial Briefs

Pennsylvania reports 1,260 measles cases across 43 counties in 2026

October 27, 2026
Two vaccine vials on a balance scale, with graphic representations of viruses in the background, symbolizing vaccines for infectious diseases.
Emergency

The rotavirus vaccine (ROTASIIL) may reduce the incidence of hospitalization for rotavirus gastroenteritis in children

September 21, 2026
Pain control after surgery collage: an older woman resting on a hospital pillow beside a teal nerve that branches at one end
Infectious Disease

Concomitant COVID-19 and influenza vaccination not linked to increased adverse events

June 29, 2026
Next Post
#VisualAbstract: Sonelokimab showed significant clinical benefit over placebo in patients with plaque psoriasis

#VisualAbstract: Convalescent plasma transfusion provides mortality benefit in early COVID-19 disease stage

Comprehensive home geriatric assessment provides similar outcomes as hospital admission

#VisualAbstract: Adjuvant pembrolizumab does not reduce health-related quality of life in patients with stage III melanoma

#VisualAbstract: Lobaplatin-based induction chemotherapy is safe and efficacious for patients with advanced nasopharyngeal carcinomas

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Pelacarsen lowers lipoprotein(a) but does not reduce major cardiovascular events in patients with established cardiovascular disease
  • Durvalumab plus enfortumab vedotin was approved for perioperative treatment of muscle-invasive bladder cancer
  • CDC reports 5,412 confirmed measles cases in the United States in 2026
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.